Faruqi & Faruqi, LLP Is Seeking More Cash For The Shareholders Of Medicis Pharmaceutical Corp. (MRX)
2012年9月15日 - 8:00AM
ビジネスワイヤ(英語)
Faruqi & Faruqi, LLP, a leading national securities firm
headquartered in New York City, is investigating the Board of
Directors of Medicis Pharmaceutical Corp. (“Medicis” or the
“Company”) (NYSE: MRX) for potential breaches of fiduciary duties
in connection with their conduct related to the sale of the Company
to Valeant Pharmaceuticals International Inc. (NYSE: VRX) in an
all-cash deal valued at approximately $2.6 billion. Under the terms
of the proposed transaction, Medicis’ stockholders will receive $44
in cash for each share of Medicis they own, while according to
Yahoo! Finance, at least one financial analyst has set a price
target of $45 for Medicis.
Request more information now by clicking here:
www.faruqilaw.com/MRX. There is no cost or
obligation to you.
Whether Medicis’ Board of Directors breached their fiduciary
duties to the Company’s stockholders by failing to conduct an
adequate and fair sales process prior to agreeing to this proposed
transaction, whether the proposed transaction undervalues Medicis’
shares and by how much this proposed transaction undervalues the
Company to the detriment of Medicis’ shareholders are the key focus
of this investigation.
Faruqi & Faruqi, LLP is a national law firm which represents
investors and individuals in class action litigation. The firm is
focused on providing exemplary legal services in complex litigation
in the areas of securities, shareholder, antitrust and consumer
litigation, throughout all phases of litigation. The firm has an
experienced trial team which has achieved significant victories on
behalf of the firm’s clients.
If you own common stock in Medicis and wish to obtain additional
information and protect your investments free of charge, please
visit us at www.faruqilaw.com/MRX or contact Juan E. Monteverde,
Esq. either via e-mail at jmonteverde@faruqilaw.com or by telephone
at (877) 247-4292 or (212) 983-9330.
Attorney Advertising. (C) 2012 Faruqi & Faruqi, LLP. The law
firm responsible for this advertisement is Faruqi & Faruqi, LLP
(www.faruqilaw.com). Prior results do not guarantee or predict a
similar outcome with respect to any future matter. We are happy to
discuss your particular case.
Medicis (NYSE:MRX)
過去 株価チャート
から 1 2025 まで 2 2025
Medicis (NYSE:MRX)
過去 株価チャート
から 2 2024 まで 2 2025
Real-Time news about Medicis Pharmaceutical Corp. (ニューヨーク証券取引所): 0 recent articles
その他のFaruqi & Faruqi, LLPニュース記事